Advances in nanotechnology for improving the targeted delivery and activity of amphotericin B (2011–2023): a systematic review-Reference-Cited by-同舟云学术

Advances in nanotechnology for improving the targeted delivery and activity of amphotericin B (2011–2023): a systematic review

Published:2024-04-02 Issue:3 Volume:18 Page:231-258
ISSN:1743-5390
Container-title:Nanotoxicology
language:en
Short-container-title:Nanotoxicology

Author:

Zadeh Mehrizi Tahereh¹,Mosaffa Nariman²,Vodjgani Mohammad³,Ebrahimi Shahmabadi Hasan⁴

Affiliation:

1. Vaccine Research Center, Iran University of Medical Sciences, Tehran, Iran

2. Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

3. Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

4. Immunology of Infectious Diseases Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences, Rafsanjan, Iran

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/17435390.2024.2340467

Reference154 articles.

1. Metronidazole conjugated magnetic nanoparticles loaded with amphotericin B exhibited potent effects against pathogenic Acanthamoeba castellanii belonging to the T4 genotype

2. Amphotericin B-loaded nanoparticles for local treatment of cutaneous leishmaniasis

3. Study the Antifungal and Ocular Permeation of Ketoconazole from Ophthalmic Formulations Containing Trans-Ethosomes Nanoparticles

4. Zinc oxide nanoparticles conjugated with clinically-approved medicines as potential antibacterial molecules

5. Amphotericin B-PEG Conjugates of ZnO Nanoparticles: Enhancement Antifungal Activity with Minimal Toxicity

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of nanotechnology to improve the antileishmanial efficacy of amphotericin B;Journal of Drug Delivery Science and Technology;2024-09